BerganKDV Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$9.46K Hold
65
﹤0.01% 560
2023
Q1
$8.4K Hold
65
﹤0.01% 626
2022
Q4
$8.29K Hold
65
﹤0.01% 604
2022
Q3
$7K Hold
65
﹤0.01% 636
2022
Q2
$7K Hold
65
﹤0.01% 652
2022
Q1
$8K Sell
65
-2
-3% -$241 ﹤0.01% 655
2021
Q4
$8K Sell
67
-252
-79% -$33K ﹤0.01% 714
2021
Q3
$45K Hold
319
0.01% 415
2021
Q2
$50K Buy
319
+59
+23% +$9.56K 0.01% 384
2021
Q1
$40K Sell
260
-13
-5% -$2.01K 0.01% 397
2020
Q4
$41K Buy
273
+188
+221% +$26.6K 0.01% 379
2020
Q3
$11K Hold
85
﹤0.01% 500
2020
Q2
$10K Buy
85
+7
+9% +$807 ﹤0.01% 547
2020
Q1
$8K Buy
+78
New +$10.2K ﹤0.01% 523
2016
Q3
Sell
-5,300
Closed -$619K 157
2016
Q2
$619K Buy
5,300
+335
+7% +$37.9K 0.26% 83
2016
Q1
$514K Buy
+4,965
New +$480K 0.31% 83

Other funds holding ZBH

BerganKDV Wealth Management's ZBH Position: Q2 2023 in Review

BerganKDV Wealth Management held its Zimmer Biomet (ZBH) position steady in Q2 2023 at 65 shares worth $9.46K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

BerganKDV Wealth Management first reported a position in ZBH in Q1 2016 and has held it in 16 quarters since. The position peaked at $619K in Q2 2016. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

  • BerganKDV Wealth Management held 65 shares of Zimmer Biomet worth $9.46K as of Q2 2023.
  • BerganKDV Wealth Management left its Zimmer Biomet share count unchanged in Q2 2023.
  • Zimmer Biomet made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #560 holding.
  • BerganKDV Wealth Management first reported a position in Zimmer Biomet in Q1 2016 and has held it in 16 quarters since.
  • BerganKDV Wealth Management's Zimmer Biomet position peaked at $619K in Q2 2016.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.